Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Bini

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
HIV Medicine|September 17, 2004
Lopinavir/ritonavir treatment in HIV antiretroviral-experienced patients: evaluation of risk factors for liver enzyme elevationP Meraviglia, M Schiavini, A Castagna, et al.
AIDS (London, England)|October 9, 1998
Clinical outcome and predictive factors of failure of highly active antiretroviral therapy in antiretroviral-experienced patients in advanced stages of HIV-1 infectionA d'Arminio Monforte, L Testa, F Adorni, et al.
The Journal of Antimicrobial Chemotherapy|August 14, 2024
Long-acting injectable antiretrovirals for HIV treatment in the ICONA cohort: physicians' and nurses' points of viewA Cingolani, A Tavelli, S De Benedittis, et al.
AIDS (London, England)|October 6, 1999
CD4 cell counts at the third month of HAART may predict clinical failureA d'Arminio Monforte, V Testori, F Adorni, et al.
Infection|March 25, 2009
Women facing HIV. Key question on women with HIV infection: Italian consensus workshopG Carosi, P Nasta, S Fiore, et al.
HIV Medicine|February 25, 2026
Peer-supported digital collection of patient-reported outcomes in HIV care: Promise, practical barriers and lessons from a pilot study within the ICONA cohortS De Benedittis, A Tavelli, R Gagliardini, et al.
Infection|January 27, 2009
Two different patterns of mutations are involved in the genotypic resistance score for atazanavir boosted versus unboosted by ritonavir in multiple failing patientsM M Santoro, A Bertoli, P Lorenzini, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
HIV Medicine|September 17, 2004
Lopinavir/ritonavir treatment in HIV antiretroviral-experienced patients: evaluation of risk factors for liver enzyme elevationP Meraviglia, M Schiavini, A Castagna, et al.
AIDS (London, England)|October 9, 1998
Clinical outcome and predictive factors of failure of highly active antiretroviral therapy in antiretroviral-experienced patients in advanced stages of HIV-1 infectionA d'Arminio Monforte, L Testa, F Adorni, et al.
The Journal of Antimicrobial Chemotherapy|August 14, 2024
Long-acting injectable antiretrovirals for HIV treatment in the ICONA cohort: physicians' and nurses' points of viewA Cingolani, A Tavelli, S De Benedittis, et al.
AIDS (London, England)|October 6, 1999
CD4 cell counts at the third month of HAART may predict clinical failureA d'Arminio Monforte, V Testori, F Adorni, et al.
Infection|March 25, 2009
Women facing HIV. Key question on women with HIV infection: Italian consensus workshopG Carosi, P Nasta, S Fiore, et al.
HIV Medicine|February 25, 2026
Peer-supported digital collection of patient-reported outcomes in HIV care: Promise, practical barriers and lessons from a pilot study within the ICONA cohortS De Benedittis, A Tavelli, R Gagliardini, et al.
Infection|January 27, 2009
Two different patterns of mutations are involved in the genotypic resistance score for atazanavir boosted versus unboosted by ritonavir in multiple failing patientsM M Santoro, A Bertoli, P Lorenzini, et al.
Pageof 4